Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ragweed allergy vaccine sublingual - Greer Laboratories

Next Previous
Drug Profile

Ragweed allergy vaccine sublingual - Greer Laboratories

Alternative Names: SAIL™ standardized short ragweed extract; Short ragweed extract immunotherapy - Greer Laboratories; Sublingual Allergy Immunotherapy Liquid

Latest Information Update: 11 Sep 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Greer Laboratories
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Seasonal allergic rhinitis

Most Recent Events

  • 14 May 2015 No recent reports on development identified - Phase-III for Seasonal allergic rhinitis in USA (Sublingual)
  • 10 Mar 2014 Development of the sublingual ragweed allergy vaccine is ongoing
  • 25 Feb 2013 Additional efficacy & adverse events data from a phase III trial in Seasonal allergic rhinitis presented at the Annual Meeting of the American Academy of Allergy Asthma & Immunology (AAAAI-2013)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top